| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD4-Positive T-Lymphocytes | 15 | 2019 | 1044 | 4.010 |
Why?
|
| Adipose Tissue | 6 | 2019 | 704 | 2.230 |
Why?
|
| Virus Replication | 6 | 2019 | 762 | 1.570 |
Why?
|
| Adipocytes | 4 | 2018 | 295 | 1.570 |
Why?
|
| HIV Infections | 14 | 2019 | 2155 | 1.360 |
Why?
|
| Granzymes | 3 | 2014 | 94 | 1.330 |
Why?
|
| HIV-1 | 10 | 2019 | 636 | 1.270 |
Why?
|
| CD28 Antigens | 5 | 2012 | 212 | 1.160 |
Why?
|
| CD8-Positive T-Lymphocytes | 7 | 2019 | 1656 | 1.000 |
Why?
|
| Flow Cytometry | 9 | 2019 | 3040 | 0.890 |
Why?
|
| HIV | 2 | 2015 | 236 | 0.870 |
Why?
|
| Immunologic Memory | 2 | 2014 | 376 | 0.750 |
Why?
|
| Viral Load | 4 | 2018 | 482 | 0.700 |
Why?
|
| Interleukin-7 | 2 | 2012 | 92 | 0.690 |
Why?
|
| CD36 Antigens | 1 | 2019 | 49 | 0.680 |
Why?
|
| Cell-Derived Microparticles | 2 | 2010 | 39 | 0.660 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2018 | 109 | 0.650 |
Why?
|
| Cyclin T | 1 | 2019 | 40 | 0.650 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2018 | 134 | 0.650 |
Why?
|
| Virus Latency | 1 | 2019 | 80 | 0.620 |
Why?
|
| DNA, Viral | 5 | 2016 | 748 | 0.620 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2018 | 55 | 0.600 |
Why?
|
| T-Lymphocytes | 7 | 2019 | 3946 | 0.600 |
Why?
|
| Anti-HIV Agents | 3 | 2018 | 356 | 0.580 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2015 | 705 | 0.570 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2016 | 709 | 0.510 |
Why?
|
| Obesity | 3 | 2019 | 2893 | 0.490 |
Why?
|
| Macaca mulatta | 4 | 2019 | 690 | 0.490 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2015 | 587 | 0.470 |
Why?
|
| Receptors, CCR5 | 1 | 2014 | 55 | 0.470 |
Why?
|
| Cell Membrane | 2 | 2008 | 880 | 0.460 |
Why?
|
| Cytokines | 7 | 2014 | 2804 | 0.450 |
Why?
|
| Interferon-gamma | 4 | 2015 | 1169 | 0.450 |
Why?
|
| Tuberculosis | 2 | 2012 | 613 | 0.430 |
Why?
|
| Macrophages | 3 | 2018 | 1334 | 0.410 |
Why?
|
| Mitogens | 1 | 2012 | 80 | 0.400 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2012 | 33 | 0.390 |
Why?
|
| Monocytes | 2 | 2016 | 784 | 0.390 |
Why?
|
| Capsid | 1 | 2012 | 177 | 0.390 |
Why?
|
| Herpesvirus 1, Human | 1 | 2012 | 115 | 0.390 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2011 | 24 | 0.390 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2011 | 28 | 0.390 |
Why?
|
| Fas Ligand Protein | 1 | 2012 | 153 | 0.380 |
Why?
|
| Tuberculin Test | 1 | 2012 | 136 | 0.370 |
Why?
|
| Apoptosis | 7 | 2012 | 7757 | 0.370 |
Why?
|
| Lymphocyte Activation | 7 | 2015 | 1719 | 0.360 |
Why?
|
| Liver | 2 | 2019 | 3061 | 0.350 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2006 | 1571 | 0.340 |
Why?
|
| Blood Chemical Analysis | 1 | 2010 | 112 | 0.340 |
Why?
|
| Cryptosporidiosis | 6 | 2008 | 93 | 0.340 |
Why?
|
| Leukocyte Common Antigens | 3 | 2017 | 191 | 0.330 |
Why?
|
| Coculture Techniques | 3 | 2018 | 626 | 0.310 |
Why?
|
| Nucleic Acids | 1 | 2008 | 44 | 0.310 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 2 | 2019 | 18 | 0.300 |
Why?
|
| Scleroderma, Systemic | 2 | 2023 | 165 | 0.290 |
Why?
|
| Cells, Cultured | 7 | 2018 | 5658 | 0.290 |
Why?
|
| Trophoblasts | 1 | 2008 | 152 | 0.290 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 5 | 2013 | 104 | 0.290 |
Why?
|
| DNA | 6 | 2023 | 3041 | 0.290 |
Why?
|
| RNA, Viral | 3 | 2019 | 715 | 0.280 |
Why?
|
| Antibodies, Monoclonal | 3 | 2012 | 4470 | 0.280 |
Why?
|
| AIDS Vaccines | 1 | 2007 | 66 | 0.270 |
Why?
|
| Leukopenia | 1 | 2006 | 152 | 0.270 |
Why?
|
| Fetus | 4 | 2006 | 670 | 0.270 |
Why?
|
| Th1 Cells | 3 | 2014 | 254 | 0.270 |
Why?
|
| Pre-Eclampsia | 1 | 2008 | 232 | 0.260 |
Why?
|
| Gene Products, vpr | 2 | 2017 | 24 | 0.260 |
Why?
|
| Plasma | 1 | 2006 | 146 | 0.250 |
Why?
|
| Humans | 57 | 2023 | 270809 | 0.250 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 302 | 0.240 |
Why?
|
| B7-1 Antigen | 1 | 2004 | 84 | 0.230 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2013 | 1136 | 0.230 |
Why?
|
| Killer Cells, Natural | 3 | 2018 | 967 | 0.220 |
Why?
|
| Cryptosporidium | 3 | 2008 | 49 | 0.220 |
Why?
|
| Hypoxia | 1 | 2006 | 469 | 0.220 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 4103 | 0.210 |
Why?
|
| CD4 Antigens | 4 | 2017 | 170 | 0.210 |
Why?
|
| Animals | 25 | 2019 | 61363 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2011 | 6344 | 0.200 |
Why?
|
| Forkhead Transcription Factors | 4 | 2010 | 762 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1416 | 0.180 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2023 | 232 | 0.180 |
Why?
|
| CD4 Lymphocyte Count | 4 | 2017 | 296 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 1503 | 0.180 |
Why?
|
| Anemia, Sickle Cell | 2 | 2018 | 364 | 0.180 |
Why?
|
| Cell Line | 7 | 2019 | 5313 | 0.180 |
Why?
|
| Interleukin-6 | 2 | 2018 | 1032 | 0.180 |
Why?
|
| PPAR alpha | 2 | 2017 | 60 | 0.170 |
Why?
|
| Antigens, CD | 3 | 2015 | 1420 | 0.170 |
Why?
|
| Prenatal Diagnosis | 5 | 2004 | 603 | 0.160 |
Why?
|
| Intestinal Mucosa | 4 | 2010 | 1112 | 0.160 |
Why?
|
| Antiretroviral Therapy, Highly Active | 4 | 2012 | 308 | 0.160 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2019 | 37 | 0.160 |
Why?
|
| Integrins | 2 | 2018 | 273 | 0.160 |
Why?
|
| Cryptosporidium parvum | 3 | 2010 | 62 | 0.160 |
Why?
|
| Signal Transduction | 7 | 2018 | 12036 | 0.160 |
Why?
|
| Vesicular Transport Proteins | 1 | 2019 | 147 | 0.150 |
Why?
|
| Tenofovir | 1 | 2018 | 22 | 0.150 |
Why?
|
| Disease Reservoirs | 1 | 2018 | 29 | 0.150 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2018 | 11 | 0.150 |
Why?
|
| Anti-Retroviral Agents | 2 | 2018 | 146 | 0.150 |
Why?
|
| Immunological Synapses | 1 | 2018 | 40 | 0.150 |
Why?
|
| Immune Evasion | 1 | 2018 | 72 | 0.150 |
Why?
|
| Sphingosine | 1 | 2018 | 59 | 0.150 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2017 | 28 | 0.150 |
Why?
|
| Karyopherins | 2 | 2019 | 134 | 0.150 |
Why?
|
| Liver X Receptors | 1 | 2017 | 25 | 0.150 |
Why?
|
| Integrin beta Chains | 1 | 2017 | 37 | 0.150 |
Why?
|
| Lysophospholipids | 1 | 2018 | 148 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 7 | 2016 | 3463 | 0.140 |
Why?
|
| Prodrugs | 1 | 2018 | 226 | 0.130 |
Why?
|
| Postprandial Period | 1 | 2016 | 83 | 0.130 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 485 | 0.130 |
Why?
|
| Fetal Blood | 3 | 2004 | 494 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 3328 | 0.130 |
Why?
|
| Receptors, CXCR4 | 1 | 2017 | 276 | 0.130 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 2986 | 0.130 |
Why?
|
| Male | 26 | 2019 | 128522 | 0.120 |
Why?
|
| Mice | 13 | 2019 | 35421 | 0.120 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2014 | 16 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2011 | 3567 | 0.120 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 2 | 2013 | 170 | 0.120 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1108 | 0.120 |
Why?
|
| Enzyme Assays | 1 | 2014 | 23 | 0.120 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2019 | 617 | 0.120 |
Why?
|
| Jurkat Cells | 3 | 2018 | 318 | 0.120 |
Why?
|
| Photopheresis | 1 | 2015 | 79 | 0.120 |
Why?
|
| Perforin | 1 | 2014 | 52 | 0.120 |
Why?
|
| Pregnancy | 9 | 2008 | 7917 | 0.120 |
Why?
|
| Lectins, C-Type | 2 | 2013 | 163 | 0.120 |
Why?
|
| Blood Donors | 1 | 2014 | 173 | 0.110 |
Why?
|
| Lymphocyte Subsets | 2 | 2012 | 137 | 0.110 |
Why?
|
| Integrin alpha4beta1 | 1 | 2013 | 45 | 0.110 |
Why?
|
| Up-Regulation | 1 | 2019 | 2413 | 0.110 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 1 | 2013 | 13 | 0.110 |
Why?
|
| Chemokines, CC | 1 | 2013 | 38 | 0.110 |
Why?
|
| Aquaporin 2 | 1 | 2013 | 6 | 0.110 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2013 | 22 | 0.110 |
Why?
|
| Neoplasms | 2 | 2019 | 15952 | 0.110 |
Why?
|
| Female | 30 | 2017 | 148940 | 0.110 |
Why?
|
| Substance P | 2 | 2003 | 75 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2014 | 162 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2016 | 367 | 0.100 |
Why?
|
| Retinal Dehydrogenase | 1 | 2013 | 84 | 0.100 |
Why?
|
| Water-Electrolyte Balance | 1 | 2013 | 99 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 617 | 0.100 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2013 | 207 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 7054 | 0.100 |
Why?
|
| Fluorescence | 2 | 2010 | 197 | 0.100 |
Why?
|
| Intestines | 2 | 2007 | 727 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 444 | 0.100 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2015 | 306 | 0.100 |
Why?
|
| Chemokine CXCL1 | 1 | 2011 | 67 | 0.100 |
Why?
|
| Methyltransferases | 1 | 2013 | 152 | 0.100 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 1096 | 0.090 |
Why?
|
| RNA Stability | 1 | 2012 | 135 | 0.090 |
Why?
|
| Cell Differentiation | 3 | 2013 | 4105 | 0.090 |
Why?
|
| Adult | 15 | 2017 | 82074 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2018 | 1246 | 0.090 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2013 | 216 | 0.090 |
Why?
|
| Vagina | 1 | 2013 | 330 | 0.090 |
Why?
|
| B-Lymphocytes | 3 | 2013 | 1420 | 0.090 |
Why?
|
| Mice, Knockout | 5 | 2018 | 5692 | 0.080 |
Why?
|
| Aneuploidy | 4 | 2004 | 382 | 0.080 |
Why?
|
| HTLV-I Infections | 1 | 2009 | 17 | 0.080 |
Why?
|
| Interleukin-5 | 1 | 2009 | 67 | 0.080 |
Why?
|
| Strongyloides stercoralis | 1 | 2009 | 26 | 0.080 |
Why?
|
| Strongyloidiasis | 1 | 2009 | 55 | 0.080 |
Why?
|
| Chemokines, CXC | 2 | 2006 | 124 | 0.080 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2006 | 90 | 0.080 |
Why?
|
| Interleukin-8 | 1 | 2011 | 528 | 0.080 |
Why?
|
| Antiparasitic Agents | 2 | 2006 | 36 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 1276 | 0.080 |
Why?
|
| Membrane Lipids | 1 | 2008 | 48 | 0.080 |
Why?
|
| HIV Core Protein p24 | 1 | 2008 | 18 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2010 | 443 | 0.080 |
Why?
|
| Adenosine | 1 | 2010 | 293 | 0.080 |
Why?
|
| Osteoprotegerin | 1 | 2008 | 29 | 0.080 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 93 | 0.080 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2008 | 71 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2017 | 6234 | 0.070 |
Why?
|
| Immunity, Cellular | 2 | 2007 | 436 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 353 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 1195 | 0.070 |
Why?
|
| Androstadienes | 1 | 2008 | 172 | 0.070 |
Why?
|
| AIDS-Related Opportunistic Infections | 2 | 2005 | 189 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2011 | 7233 | 0.070 |
Why?
|
| Cell Separation | 2 | 2006 | 608 | 0.070 |
Why?
|
| CD4-CD8 Ratio | 1 | 2007 | 57 | 0.070 |
Why?
|
| Annexin A5 | 1 | 2007 | 74 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2007 | 167 | 0.070 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2006 | 367 | 0.070 |
Why?
|
| Vaccination | 1 | 2013 | 1113 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2013 | 825 | 0.070 |
Why?
|
| HIV Antibodies | 1 | 2007 | 95 | 0.070 |
Why?
|
| Neutralization Tests | 1 | 2007 | 236 | 0.070 |
Why?
|
| Protozoan Proteins | 1 | 2007 | 121 | 0.070 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2007 | 149 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 464 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 205 | 0.070 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 364 | 0.070 |
Why?
|
| Genetic Techniques | 1 | 2006 | 150 | 0.060 |
Why?
|
| Microspheres | 1 | 2006 | 235 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2010 | 1875 | 0.060 |
Why?
|
| Multiple Organ Failure | 1 | 2006 | 176 | 0.060 |
Why?
|
| Shock, Septic | 1 | 2006 | 188 | 0.060 |
Why?
|
| Macrophages, Alveolar | 1 | 2004 | 70 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 248 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2005 | 266 | 0.060 |
Why?
|
| Interleukin-15 | 1 | 2005 | 197 | 0.060 |
Why?
|
| Digestion | 1 | 2023 | 39 | 0.060 |
Why?
|
| Middle Aged | 11 | 2017 | 90570 | 0.050 |
Why?
|
| Sex Determination Analysis | 1 | 2003 | 21 | 0.050 |
Why?
|
| Capsid Proteins | 1 | 2004 | 219 | 0.050 |
Why?
|
| Interleukin-2 | 1 | 2007 | 889 | 0.050 |
Why?
|
| JC Virus | 1 | 2003 | 48 | 0.050 |
Why?
|
| Endodeoxyribonucleases | 1 | 2023 | 115 | 0.050 |
Why?
|
| Taurochenodeoxycholic Acid | 1 | 2002 | 5 | 0.050 |
Why?
|
| Rotavirus Infections | 2 | 2004 | 352 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 1944 | 0.050 |
Why?
|
| Biomarkers | 1 | 2014 | 5050 | 0.050 |
Why?
|
| Blood Cells | 1 | 2003 | 127 | 0.050 |
Why?
|
| Pulmonary Emphysema | 1 | 2004 | 159 | 0.050 |
Why?
|
| Cholagogues and Choleretics | 1 | 2002 | 38 | 0.050 |
Why?
|
| Young Adult | 3 | 2017 | 22255 | 0.050 |
Why?
|
| Neurocysticercosis | 1 | 2002 | 27 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2007 | 1273 | 0.050 |
Why?
|
| Antigens, Viral | 1 | 2004 | 495 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 4 | 2013 | 2419 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 3 | 2003 | 2312 | 0.050 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 4198 | 0.050 |
Why?
|
| Somatostatin | 1 | 2002 | 121 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2004 | 813 | 0.050 |
Why?
|
| Polyomavirus Infections | 1 | 2003 | 147 | 0.050 |
Why?
|
| Cellular Senescence | 1 | 2004 | 389 | 0.050 |
Why?
|
| Gestational Age | 2 | 2002 | 1160 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2005 | 669 | 0.050 |
Why?
|
| Tumor Virus Infections | 1 | 2003 | 248 | 0.050 |
Why?
|
| Blood | 1 | 2002 | 164 | 0.050 |
Why?
|
| Rotavirus | 1 | 2004 | 498 | 0.050 |
Why?
|
| Granuloma | 1 | 2002 | 151 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2002 | 330 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 7323 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2018 | 2087 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2002 | 640 | 0.040 |
Why?
|
| RNA Transport | 1 | 2019 | 13 | 0.040 |
Why?
|
| Hepatocytes | 2 | 2017 | 335 | 0.040 |
Why?
|
| Caspases | 1 | 2002 | 672 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 5157 | 0.040 |
Why?
|
| Diarrhea | 1 | 2003 | 722 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2002 | 574 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 959 | 0.040 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2003 | 481 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 2018 | 46 | 0.040 |
Why?
|
| Chromosome Aberrations | 2 | 2002 | 2035 | 0.040 |
Why?
|
| Caco-2 Cells | 2 | 2010 | 160 | 0.040 |
Why?
|
| Time Factors | 2 | 2013 | 12979 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 267 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2017 | 184 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2019 | 702 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 738 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2018 | 211 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 691 | 0.030 |
Why?
|
| Chemokine CXCL10 | 2 | 2006 | 104 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 1064 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2002 | 1362 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2006 | 3429 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2018 | 669 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 474 | 0.030 |
Why?
|
| Gene Expression | 1 | 2002 | 3606 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 1715 | 0.030 |
Why?
|
| Cell-Free System | 2 | 2004 | 174 | 0.030 |
Why?
|
| Chromosomes, Human, Y | 2 | 2004 | 52 | 0.030 |
Why?
|
| Chromatography, Thin Layer | 1 | 2013 | 69 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2015 | 317 | 0.030 |
Why?
|
| 3T3-L1 Cells | 1 | 2013 | 69 | 0.030 |
Why?
|
| Aged | 7 | 2016 | 73641 | 0.030 |
Why?
|
| Adolescent | 3 | 2012 | 32698 | 0.030 |
Why?
|
| Inflammation | 2 | 2018 | 2491 | 0.030 |
Why?
|
| Polyuria | 1 | 2013 | 12 | 0.030 |
Why?
|
| Acid-Base Imbalance | 1 | 2013 | 30 | 0.030 |
Why?
|
| Protein Binding | 1 | 2019 | 3472 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2013 | 139 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2013 | 224 | 0.030 |
Why?
|
| Genomics | 1 | 2023 | 2834 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 14886 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 887 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 355 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 15280 | 0.020 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2013 | 98 | 0.020 |
Why?
|
| CD8 Antigens | 1 | 2012 | 174 | 0.020 |
Why?
|
| Integrases | 1 | 2013 | 254 | 0.020 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2010 | 13 | 0.020 |
Why?
|
| Methylation | 1 | 2013 | 625 | 0.020 |
Why?
|
| Xanthines | 1 | 2010 | 28 | 0.020 |
Why?
|
| B7-H1 Antigen | 1 | 2018 | 1098 | 0.020 |
Why?
|
| Adenosine Deaminase | 1 | 2010 | 113 | 0.020 |
Why?
|
| Hemolysis | 1 | 2010 | 125 | 0.020 |
Why?
|
| Antibodies, Protozoan | 1 | 2010 | 71 | 0.020 |
Why?
|
| Antigens, Protozoan | 1 | 2010 | 67 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 2393 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 699 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 464 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2005 | 1825 | 0.020 |
Why?
|
| Antigens, Helminth | 1 | 2009 | 156 | 0.020 |
Why?
|
| Spleen | 1 | 2010 | 719 | 0.020 |
Why?
|
| Host-Parasite Interactions | 1 | 2008 | 67 | 0.020 |
Why?
|
| Disease Progression | 2 | 2013 | 6881 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2008 | 153 | 0.020 |
Why?
|
| Lung | 2 | 2010 | 3287 | 0.020 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 210 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2010 | 593 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2006 | 36 | 0.020 |
Why?
|
| Antibodies, Viral | 2 | 2004 | 1218 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2013 | 1104 | 0.020 |
Why?
|
| Ferrosoferric Oxide | 1 | 2006 | 39 | 0.020 |
Why?
|
| Receptors, Natural Killer Cell | 1 | 2005 | 16 | 0.020 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2005 | 56 | 0.020 |
Why?
|
| Chemokines | 1 | 2006 | 285 | 0.020 |
Why?
|
| Histones | 1 | 2013 | 1512 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 1439 | 0.020 |
Why?
|
| Ileum | 1 | 2005 | 173 | 0.020 |
Why?
|
| Receptors, CXCR3 | 1 | 2004 | 34 | 0.020 |
Why?
|
| Animals, Outbred Strains | 1 | 2004 | 14 | 0.010 |
Why?
|
| Peyer's Patches | 1 | 2004 | 30 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 113 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 431 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2004 | 237 | 0.010 |
Why?
|
| Random Allocation | 1 | 2005 | 728 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 310 | 0.010 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2003 | 5 | 0.010 |
Why?
|
| Virion | 1 | 2004 | 185 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 9054 | 0.010 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2003 | 45 | 0.010 |
Why?
|
| Caspase 12 | 1 | 2002 | 7 | 0.010 |
Why?
|
| Caspase 7 | 1 | 2002 | 30 | 0.010 |
Why?
|
| Thapsigargin | 1 | 2002 | 43 | 0.010 |
Why?
|
| Taenia | 1 | 2002 | 13 | 0.010 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2002 | 167 | 0.010 |
Why?
|
| Pregnancy Trimester, First | 1 | 2002 | 122 | 0.010 |
Why?
|
| Jejunum | 1 | 2003 | 229 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 2102 | 0.010 |
Why?
|
| Erythroid Precursor Cells | 1 | 2002 | 70 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2002 | 99 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 2478 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2002 | 253 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 697 | 0.010 |
Why?
|
| Kinetics | 1 | 2004 | 2206 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 460 | 0.010 |
Why?
|
| Mothers | 1 | 2004 | 406 | 0.010 |
Why?
|
| Granulocytes | 1 | 2002 | 244 | 0.010 |
Why?
|
| Megakaryocytes | 1 | 2002 | 128 | 0.010 |
Why?
|
| Cell Count | 1 | 2002 | 509 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 350 | 0.010 |
Why?
|
| Hyperplasia | 1 | 2002 | 571 | 0.010 |
Why?
|
| Placenta | 1 | 2004 | 562 | 0.010 |
Why?
|
| Down Syndrome | 1 | 2002 | 227 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2004 | 541 | 0.010 |
Why?
|
| Mosaicism | 1 | 2002 | 294 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 2003 | 457 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 1801 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2005 | 2855 | 0.010 |
Why?
|
| Liver Diseases | 1 | 2002 | 601 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 3582 | 0.010 |
Why?
|
| Base Sequence | 1 | 2003 | 5406 | 0.010 |
Why?
|
| Calcium | 1 | 2002 | 1571 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 1286 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 6639 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 1293 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 7647 | 0.010 |
Why?
|
| Smoking | 1 | 2004 | 2549 | 0.010 |
Why?
|
| Prognosis | 1 | 2013 | 22533 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 4249 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2003 | 1692 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2015 | 39982 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2002 | 5146 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2003 | 5779 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2004 | 7789 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2003 | 13422 | 0.000 |
Why?
|
| Mutation | 1 | 2003 | 15922 | 0.000 |
Why?
|